The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4.
about
Phosphodiesterase regulation of alcohol drinking in rodents.Phosphodiesterase type 4 inhibitors: potential in the treatment of multiple sclerosis?The effects of phosphodiesterase type 4 inhibitors on tumour necrosis factor-alpha and leukotriene B4 in a novel human whole blood assay.Effect of the glucocorticosteroid budesonide and a novel phosphodiesterase type 4 inhibitor CDP840 on antigen-induced airway responses in neonatally immunised rabbits.Cytotoxicity of Zardaverine in Embryonal Rhabdomyosarcoma from a Costello Syndrome Patient.Phosphodiesterase inhibitors.CDP840: a novel inhibitor of PDE-4.Phosphodiesterase isozymes: molecular targets for novel antiasthma agents.Inhibition of pulmonary eosinophilia and airway hyperresponsiveness in allergic mice by rolipram: involvement of endogenously released corticosterone and catecholamines.Inhibition of bronchospasm and ozone-induced airway hyperresponsiveness in the guinea-pig by CDP840, a novel phosphodiesterase type 4 inhibitorInhibition of eotaxin-mediated human eosinophil activation and migration by the selective cyclic nucleotide phosphodiesterase type 4 inhibitor rolipram.Arylation of diazoesters by a transient N-H insertion organocascade.Overview of animal models of asthma.PDE4 inhibition and a corticosteroid in chronically antigen exposed conscious guinea-pigs.1,6-Conjugate addition of zinc alkyls to para-quinone methides in a continuous-flow microreactor.The therapeutic potential of PDE4 inhibitors.
P2860
Q28394978-6C1D6731-ED85-48F5-90F3-655B2CCF6913Q34717832-D64C830A-5372-48D3-9259-B89B91A0548BQ35041052-3BCC9334-D995-4219-806C-88AD0A1C41F4Q35873675-3B035011-9B43-4829-811D-9EA1635AC60EQ36350472-BADD93ED-B4C4-4904-8549-4E1B2D53D4BBQ36364429-3909B726-48AD-48BA-8D14-6D0D37C32C76Q36897167-5A013B25-E0EB-486C-AC4F-C3D1ADAB102EQ41708863-F8243518-94CE-4F1E-8E5B-1441DE786D7BQ41811998-2C72E88F-F42F-4617-AED8-D5C32F30E2ABQ42704494-8DE6623E-2601-40B9-A34A-D764013C650CQ43174096-351E1CD0-B86D-48CC-AF3C-2CA1F8820329Q43545362-DE4C5549-816B-4151-8488-4200EE97DB1FQ46342761-47E1E40D-C49C-458D-A005-448F05BECB71Q46835222-50213C0D-70F7-4F15-BC4F-D360B20211E8Q48236743-C79C4923-0C92-4BDB-893E-9A81C5B5F28FQ53619316-8DAD9D2D-B945-4240-A1A6-9E2337B7002F
P2860
The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
The inhibition of antigen-indu ...... r of phosphodiesterase type 4.
@ast
The inhibition of antigen-indu ...... r of phosphodiesterase type 4.
@en
type
label
The inhibition of antigen-indu ...... r of phosphodiesterase type 4.
@ast
The inhibition of antigen-indu ...... r of phosphodiesterase type 4.
@en
prefLabel
The inhibition of antigen-indu ...... r of phosphodiesterase type 4.
@ast
The inhibition of antigen-indu ...... r of phosphodiesterase type 4.
@en
P2093
P2860
P1476
The inhibition of antigen-indu ...... r of phosphodiesterase type 4.
@en
P2093
Alexander R
Catterall C
P2860
P304
P356
10.1111/J.1476-5381.1996.TB15522.X
P407
P577
1996-07-01T00:00:00Z